The development and appraisal of a tool designed to find patients harmed by falsely labelled, falsified (counterfeit) medicines

BACKGROUND: Falsely labelled, falsified (counterfeit) medicines (FFCm’s) are produced or distributed illegally and can harm patients. Although the occurrence of FFCm’s is increasing in Europe, harm is rarely reported. The European Directorate for the Quality of Medicines & Health-Care (EDQM) has...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMC Health Serv Res
Huvudupphovsmän: Anđelković, Marija, Björnsson, Einar, De Bono, Virgilio, Dikić, Nenad, Devue, Katleen, Ferlin, Daniel, Hanževački, Miroslav, Jónsdóttir, Freyja, Shakaryan, Mkrtich, Walser, Sabine
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2017
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5477164/
https://ncbi.nlm.nih.gov/pubmed/28633634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-017-2235-y
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk